Literature DB >> 10362363

Mutational analysis of p73 and p53 in human cancer cell lines.

H Yoshikawa1, M Nagashima, M A Khan, M G McMenamin, K Hagiwara, C C Harris.   

Abstract

p73 is a candidate tumor suppressor gene with substantial DNA and protein homology to the p53 tumor suppressor gene. We have investigated two hypotheses: (a) p73 is mutated in diverse types of human cancer, and (b) p73 is functionally redundant with p53 in carcinogenesis so that mutations would be exclusive in these two genes. The entire coding region and intronic splice junctions of p73 were examined in 54 cancer cell lines. Three lung cancer cell lines contained mutations that affected the amino acid sequence. One amino acid substitution was in a region with homology to the specific DNA binding region of p53 and two microdeletions were outside the region of homology. Two of the cell lines with p73 mutations also carried p53 mutations. Although our results are inconsistent with the two hypotheses tested, p73 mutations may contribute infrequently to the molecular pathogenesis of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362363     DOI: 10.1038/sj.onc.1202677

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line.

Authors:  Sakae Maeda; Hiroshi Wada; Yoko Naito; Hiroaki Nagano; Szandor Simmons; Yoshinori Kagawa; Atsushi Naito; Junichi Kikuta; Taeko Ishii; Yoshito Tomimaru; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Hidetoshi Eguchi; Koji Umeshita; Hideshi Ishii; Yuichiro Doki; Masaki Mori; Masaru Ishii
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

2.  Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

Authors:  L Thorstensen; H Qvist; S Heim; G J Liefers; J M Nesland; K E Giercksky; R A Lothe
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

3.  Effect of combined 5-aza-2'deoxycytidine and cisplatin treatment on the P15 lung adenocarcinoma cell line.

Authors:  Kaishan Liu; Wenyan Huang; Weisong Gao; Wenfang He
Journal:  Oncol Lett       Date:  2015-02-26       Impact factor: 2.967

4.  Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells.

Authors:  Andrew M Rankin; Sibaji Sarkar; Douglas V Faller
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Proteasome inhibitors suppress the protein expression of mutant p53.

Authors:  Marianna Halasi; Bulbul Pandit; Andrei L Gartel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 6.  Alterations of p63 and p73 in human cancers.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Subcell Biochem       Date:  2014

7.  Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.

Authors:  Michalis Liontos; Katerina Niforou; Georgia Velimezi; Konstantinos Vougas; Konstantinos Evangelou; Kalliopi Apostolopoulou; Radek Vrtel; Alexandros Damalas; Panayiotis Kontovazenitis; Athanassios Kotsinas; Vassilis Zoumpourlis; George Th Tsangaris; Christos Kittas; Doron Ginsberg; Thanos D Halazonetis; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

8.  Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines.

Authors:  Nandan Bhattacharyya; Huan-Chao Chen; Liming Wang; Spira Banerjee
Journal:  Gene Expr       Date:  2002

Review 9.  Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Authors:  Li-Dong Wang; Shu Zheng; Zuo-Yu Zheng; Alan G Casson
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Local mitochondrial-endolysosomal microfusion cleaves voltage-dependent anion channel 1 to promote survival in hypoxia.

Authors:  M Christiane Brahimi-Horn; Sandra Lacas-Gervais; Ricardo Adaixo; Karine Ilc; Matthieu Rouleau; Annick Notte; Marc Dieu; Carine Michiels; Thibault Voeltzel; Véronique Maguer-Satta; Joffrey Pelletier; Marius Ilie; Paul Hofman; Bénédicte Manoury; Alexander Schmidt; Sebastian Hiller; Jacques Pouysségur; Nathalie M Mazure
Journal:  Mol Cell Biol       Date:  2015-02-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.